Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT03104582
Other study ID # Biliary drainage in KT
Secondary ID
Status Completed
Phase N/A
First received
Last updated
Start date November 1, 2011
Est. completion date July 14, 2017

Study information

Verified date July 2019
Source Hepatopancreatobiliary Surgery Institute of Gansu Province
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

To investigate the biliary drainage-related cholangitis and other complications of percutaneous transhepatic biliary drainage (PTBD) in the management of Klatskin tumor (KT) compared with endoscopic biliary drainage (EBD).


Description:

Operative treatment combined with preoperative biliary drainage (PBD) has been established as a safe management strategy for KT. Preoperative cholangitis was an independent risk factor for patients undergoing resection for KT. However, controversy exists regarding the preferred technique for PBD.


Recruitment information / eligibility

Status Completed
Enrollment 180
Est. completion date July 14, 2017
Est. primary completion date July 14, 2017
Accepts healthy volunteers No
Gender All
Age group 18 Years to 90 Years
Eligibility Inclusion Criteria:

- Type II?III?IV Klatskin tumor patients;

- 18-90 years old

Exclusion Criteria:

- Unwillingness or inability to consent for the study;

- Coagulation dysfunction (INR> 1.3) and low peripheral blood platelet count(<50×109 / L) or using anti-coagulation drugs;

- Previous endoscopic sphincterectomy (EST) or endoscopic papillary balloon dilatation (EPBD);

- Any type of GI reconstruction;

- Combined with Mirizzi syndrome and intrahepatic bile duct stones;

- Preoperative coexistent diseases: acute pancreatitis, GI tract hemorrhage, severe liver disease, primary sclerosing cholangitis (PSC), septic shock;

- Biliary-duodenal fistula;

- Pregnant women

Study Design


Related Conditions & MeSH terms


Intervention

Procedure:
ERCP Drainage
When advanced Klatskin Tumor patients need biliary drainage, they choose to perform endoscopic drainage after informed consent.
PTBD Drainage
When advanced Klatskin Tumor patients need biliary drainage, they choose to perform percutaneous transhepatic biliary drainage after informed consent.

Locations

Country Name City State
China Hepatopancreatobiliary Surgery Institute of Gansu Province Lanzhou Gansu

Sponsors (1)

Lead Sponsor Collaborator
Hepatopancreatobiliary Surgery Institute of Gansu Province

Country where clinical trial is conducted

China, 

Outcome

Type Measure Description Time frame Safety issue
Primary Acute cholangitis Acute cholangitis is defined if patients experienced abdominal pain, high fever, or chill after procedure in 2 weeks 2 weeks
Secondary Abdominal pain Pain score (scores:1-10) 2 weeks
Secondary Length of hospital stay The total time of hospital stay 6 months
Secondary Overall procedure related complication rate Pancreatitis, bleeding, perforation, seeding 6 months
See also
  Status Clinical Trial Phase
Completed NCT02917408 - Retrospective Study About Primary Biliary Cholangitis During January 2001 to July 2016 at West China Hospital
Withdrawn NCT02543957 - Factors Associated With Increased Risk of Bacteremia and Cholangitis in ERCP With Cholangioscopy
Completed NCT02461147 - Prospective Validation of "Cholecystectomy First" Strategy for Gallstone Migration
Completed NCT01824186 - Trial Comparing Pain in Single-incision Laparoscopic Cholecystectomy Versus Conventional Laparoscopic Cholecystectomy N/A
Terminated NCT00990366 - Treatment of Biliary Obstruction Using Biliary Stent With or Without Antireflux Valve N/A
Completed NCT02594891 - Effect of 8.5 F Plastic Stent Without Proximal Flap on Prevention of Post-ERCP Cholangitis N/A
Terminated NCT01142921 - The Patency Period of the New Plastic Anti-reflux Biliary Stent N/A
Completed NCT04604652 - Open-Label Study of HTD1801 in Adult Subjects With Primary Biliary Cholangitis Phase 2
Terminated NCT02034279 - The INFECIR-2 Albumin Prevention Study Phase 4
Completed NCT04671095 - Single Use ERCP Performance -SURE Study
Recruiting NCT03087656 - Antibiotics to Decrease Post ERCP Cholangitis Phase 4
Completed NCT02098486 - Comparisons of Intravenous Ceftriaxone With Intravenous Moxifloxacin in ERCP Phase 2
Withdrawn NCT03678480 - A Study of HTD1801 in Adolescents With Primary Sclerosing Cholangitis (PSC) Phase 2
Recruiting NCT04216745 - Microbial Analysis in Patients With Cholangitis
Recruiting NCT03133026 - Cholangioscopic Assessment of Occluded Biliary Stent and Role of Biliary Radiofrequency Ablation N/A
Terminated NCT02618668 - Haemodynamic Stability of Ketamine/Propofol Admixture "Ketofol" in Patient Undergoing Endoscopic Retrograde Cholangio Pancreatography Phase 2
Recruiting NCT01438385 - Interventional Endoscopy Database for Pancreatico-biliary, Gastrointestinal and Esophageal Disorders N/A
Recruiting NCT05750966 - Short-course Antibiotics vs Standard Course Antibiotics in Patients With Cholangitis N/A
Recruiting NCT06111872 - Ketamine-midazolam as a Sedative Agent in Endoscopic Retrograde Cholangiopancreatography. Phase 2
Recruiting NCT05464303 - Definition for Biliary Atresia Associated Cholangitis After Surgery